A possible relationship between the anti-cancer potency of photodynamic therapy using the novel photosensitizer ATX-s10-Na(II) and expression of the vascular endothelial growth factor in vivo

Oncology Reports

Volumn 18, Issue 3, 2007, Pages 679-683

  Okunaka, T ^a   Usuda, Jitsuo ^b   Ichinose, S ^b   Hirata, H ^b   Ohtani, K ^b   Maehara, S ^b   Inoue, T ^b   Imai, K ^b   Kubota, M ^b   Tsunoda, Y ^a   Kuroiwa, Y ^a   Tsutsui, H ^a   Furukawa, K ^c   Nishio, K ^d   Kato, H ^b  

^a INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c Tokyo Medical University Ibaraki Medical Center   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Photodynamic therapy; Photosensitizer; Vascular endothelial growth factor

Indexed keywords

ATX S10NA(II); DNA; PHOTOSENSITIZING AGENT; PORPHYRIN; RNA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LUNG TUMOR; MOUSE; NUDE MOUSE; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38449091608     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.3.679     Document Type: Article

References (30)

1. Dougherty TJ, Gomer CJ, Barbara WH, et al: Photodynamic therapy. J Natl Cancer Inst 90: 889-905, 1998. (Pubitemid 28304157)
2. Oleinick NL, Morris RL and Belichenko I: The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 1: 1-21, 2001.
3. Usuda J, Kato H, Okunaka T, et al: Photodynamic therapy (PDT) for lung cancers. J Thorac Oncol 1: 489-493, 2006. (Pubitemid 47181428)
4. Kato H, Usuda J, Okunaka T, et al: Basic and clinical research on photodynamic therapy at Tokyo Medical University Hospital. Lasers Surg Med 38: 371-375, 2006.
5. Dougherty TJ: An update on photodynamic therapy applications. J Clin Laser Med Surg 20: 3-7, 2002.
6. Kato H, Furukawa K, Sato M, et al: Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorine e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 42: 103-111, 2003. (Pubitemid 37153142)
7. Dougherty TJ, Lawrence G, Kaufman JH, et al: Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 62: 231-237, 1979. (Pubitemid 9094709)
8. Loewen GM, Pandy R, Bellnier D, et al: Endobronchial photodynamic therapy for lung cancers. Lasers Surg Med 38: 364-370, 2006.
9. Mathur PN, Edell E, Sutedja T, et al: Treatment of early stage non-small cell lung cancer. Chest 123: 176-180, 2006.
10. Kamuhabwa AR, Huygens A, Roskams T, et al: Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin. Int J Oncol 28: 775-780, 2006.
11. Gomer CJ, Ferrario A, Luna M, et al: Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment. Lasers Surg Med 38: 516-521, 2006.
12. Mori M, Sakata I, Hirano T, et al: Photodynamic therapy for experimental tumors using ATX-s10 (Na), a hydrophilic chlorine for photosensitizer, and diode laser. Jpn J Cancer Res 91: 753-759, 2000. (Pubitemid 30612361)
13. Huang Y, Obana A, Gohto Y, et al: Comparative study of the phototoxicity of two chlorine type photosensitizer, ATX-s10 (Na) and Verteporfin, on vascular endothelial and retinal pigment epithelial cells. Lasers Surg Med 34: 2116-2226, 2004.
14. Masumoto K, Yamada I, Tanaka H, et al: Tissue distribution of a new photosensitizer ATX-s10 (Na) (II) and effect of a diode laser laser (670 nm) in photodynamic therapy. Lasers Surg Sci 18: 134-138, 2003. (Pubitemid 37210317)
15. Ichinose S, Usuda J, Hirata T, et al: Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na). Int J Oncol 29: 349-355, 2006.
16. Usuda J, Okunaka T, Furukawa K, et al: Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected via enhanced apoptosis. Int J Cancer 93: 475-480, 2001. (Pubitemid 32701405)
17. Chen B, Pogue BW, Zhou X, et al: Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model. Clin Cancer Res 11: 720-727, 2005. (Pubitemid 40116900)
18. Huang Z, Chen Q, Luck D, et al: Studies of a vascular-acting photosensitizer, Pd-Bacteriopheophorbide (Tookad), normal canine prostate and spontaneous canine prostate cancer. Lasers Surg Med 36: 390-397, 2005. (Pubitemid 40942154)
19. Sitnik TM, Hampton JA, Henderson BW, et al: Reduction of tumor oxygenation during and after photodynamic therapy in vivo: effect of fluence rate. Br J Cancer 77: 1386-1394, 1998. (Pubitemid 28190737)
20. Ferrario A, von Tiehl KF, Rucker N, et al: Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res 60: 4066-4069, 2000. (Pubitemid 30636586)
21. Natsume T, Watanabe J, Koh Y, et al: Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo . Cancer Sci 94: 826-833, 2003. (Pubitemid 37258783)
22. Koizumi F, Kitagawa M, Negishi T, et al: Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res 66: 100048-100056, 2006.
23. Nakamura H, Saji H, Ogata A, et al: cDNA microarray analysis of gene expression in pathologic stage IA non-small cell lung cancer. Cancer 97: 2798-2805, 2003. (Pubitemid 36605148)
24. Natsume T, Koh Y, Kobayashi M, et al: Enhanced antitumor activities of TZT-1027 against TNF-alpha or IL-6 secreting Lewis lung carcinoma in vivo . Cancer Chemother Pharmacol 49: 33-47, 2002.
25. Usuda J, Azizuddin K, Chiu SM, et al: Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy. Photochem Photobiol 78: 1-8, 2003.
26. Ferrario A, Chantrain CF, von Tiehl Karl, et al: The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res 64: 2328-2332, 2004. (Pubitemid 38523882)
27. Oyadomori S and Mori M: Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-389, 2004.
28. Wong S, Luna M, Ferrario A, et al: CHOP activation by photodynamic therapy increases treatment induced photosensitization. Lasers Surg Med 35: 336-341, 2004.
29. Gollnick SO, Liu X, Owczarzak B, et al: Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res 57: 3904-3909, 1997. (Pubitemid 27427673)
30. Jiang F, Zhang ZG, Katakowski M, et al: Angiogenesis induced by photodynamic therapy in normal rat brain. Photochem Photobiol 79: 494-498, 2004. Technology